Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)
Mark F. Bird(University of Leicester), David G. Lambert(Griffith University), Carla Ghelardini(Creative Commons), Girolamo Calò(University of Padua), Paola Molinari, Maria Camilla Cerlesi(University of Ferrara), Vanessa Vezzi(Istituto Superiore di Sanità), Lorenzo Di Cesare Mannelli(University of Florence), Laura Micheli(University of Florence), Mark J. Brown(University of Leicester), Davide Malfacini(University of Bonn), Renzo Guerrini(Meyer Children's Hospital)
Cited by 55
Related Papers
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
Somatic Mutations in Cerebral Cortical Malformations
|New England Journal of Medicine|2014|394